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AbstrACt
Introduction Depression is highly prevalent and the 
leading contributor to the burden of disease in young 
people worldwide, making it an ongoing priority for early 
intervention. As the current evidence-based interventions 
of medication and psychological therapy are only modestly 
effective, there is an urgent need for additional treatment 
strategies. This paper describes the rationale of the 
Improving Mood with Physical ACTivity (IMPACT) trial. 
The primary aim of the IMPACT trial is to determine the 
effectiveness of a physical activity intervention compared 
with psychoeducation, in addition to routine clinical care, 
on depressive symptoms in young people. Additional 
aims are to evaluate the intervention effects on anxiety 
and functional outcomes and examine whether changes 
in physical activity mediate improvements in depressive 
symptoms.
Methods and analysis The study is being conducted 
in six youth mental health services across Australia and 
is using a parallel-group, two-arm, cluster randomised 
controlled trial design, with randomisation occurring at the 
clinician level. Participants aged between 12 years and 
25 years with moderate to severe levels of depression are 
randomised to receive, in addition to routine clinical care, 
either: (1) a physical activity behaviour change intervention 
or (2) psychoeducation about physical activity. The 
primary outcome will be change in the Quick Inventory of 
Depressive Symptomatology, with assessments occurring 
at baseline, postintervention (end-point) and 6-month 
follow-up from end-point. Secondary outcome measures 
will address additional clinical outcomes, functioning and 
quality of life. IMPACT is to be conducted between May 
2014 and December 2019.
Ethics and dissemination Ethical approval was obtained 
from the University of Melbourne Human Research Ethics 
Committee on 8 June 2014 (HREC 1442228). Trial findings 
will be published in peer-reviewed journals and presented 
at conferences. Key messages will also be disseminated 
by the youth mental health services organisation 
(headspace National Youth Mental Health Foundation).
trial registration number ACTRN12614000772640.
bACkground
Depression is highly prevalent1 and is the 
leading cause of disability in young people 
strengths and limitations of this study
 ► The study is a cluster randomised controlled trial, 
which reduces the risk of contamination bias and 
uses validated outcome measures.
 ► The study is conducted in real-world clinical ser-
vices, which increases the likelihood of translation 
into practice.
 ► A large number of participants needs to be recruited 
to provide sufficient power to demonstrate a rele-
vant effect size.
 ► Limited capacity to provide ongoing supervision for 
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worldwide.2 Associated adverse consequences include 
impairments in academic attainment and achievement,3 
unemployment or underemployment,3 and increased 
risk of self-harm and suicide.4 Effective treatments have 
the potential to improve the health and functioning of 
young people and prevent the entrenchment of prob-
lems with relationships, education and health.5 The 
current international evidence-based clinical practice 
guideline for treating depression in children and young 
people recommends cognitive–behavioural therapy 
(CBT) as the first-line treatment for moderate to severe 
depression, with or without the antidepressant medica-
tion, fluoxetine.6 Recent evidence from meta-analyses 
of randomised controlled trials (RCTs) have shown the 
effect sizes of both CBT and antidepressant medication 
are smaller than previously reported.7–9 This suggests that 
many young people either fail to respond or do not show 
a clinically significant change even after receiving the best 
available guideline-recommended treatment delivered in 
controlled trials.7 10
With such modest effects of first-line treatments, there 
is a need for additional therapeutic strategies. One such 
strategy with an emerging evidence base is exercise or 
physical activity as an augmentation or adjunct treat-
ment.11 Large cross-sectional and cohort studies show 
that less physically active young people are currently 
more likely to be depressed and are at greater risk of 
developing future depression.12 13 While insufficient phys-
ical activity places all young people at greater risk of poor 
physical health, including higher rates of cardiovascular 
disease, diabetes and premature death,14 15 young people 
with depression are far more likely to be physically inac-
tive than the general population, placing them at higher 
risk of long-term poorer physical health.16 17 In addition 
to mental and physical health benefits, physical activity 
is a low-stigma intervention that has few side effects.18 19 
Both of these factors are important to help-seeking young 
people.20
There is strong evidence from RCTs and meta-analyses 
that physical activity is an effective intervention for depres-
sion in adults (standard mean difference (SMD)=1.135, 
p<0.001)21 and reduces the risk of suicidal ideation.22 
Although not as robust as the evidence base for adults,21 
physical activity interventions for young people with 
depression show similar findings.23–25 A recent meta-anal-
ysis, conducted by members of our investigator team, of 
RCTs in young people aged 12–25 years established that 
physical activity is effective in reducing depression symp-
toms.26 Data from 771 participants across 16 trials showed 
a large effect of supervised physical activity interventions 
on depression symptoms compared with controls in 
subthreshold samples (SMD=−0.82, p<0.01). The effect 
remained robust in five trials of young people with a diag-
nosis of depression (SMD=−0.72, p<0.01). However, clin-
ical applications are hindered by the majority of studies 
being of low quality, lack of longer term follow-up and 
inadequate consideration of real-world implementation 
factors.26
Our group developed an intervention and evaluated it 
in the first RCT examining the potential benefits of low-in-
tensity, simple psychological and unsupervised physical 
activity interventions for young people (n=176) with high 
prevalence mental health problems,25 implemented within 
community-based youth mental health services. Conducted 
in two such services in the western region of Melbourne, 
Australia, the trial used a factorial design to compare the 
effects of a psychological intervention (problem solving 
therapy vs supportive counselling) and a physical activity 
intervention (behavioural change vs psychoeducation) 
delivered in up six sessions (an average of 4.3 sessions were 
completed). Importantly, we recruited men and women, 
making this the first physical activity study to be conducted 
with young men with depression or anxiety symptoms. The 
physical activity intervention focused on addressing barriers 
to engaging in physical activity and creating individualised 
activity plans. Postintervention data showed the main effect 
of the physical activity intervention was significant when 
compared with the control condition (psychoeducation), 
resulting in a clinically meaningful reduction in depression 
symptoms with a medium effect size (d=0.41; (95% CI 0.07 
to 0.76)), measured by the Beck Depression Inventory.27 
Those in the physical activity intervention group reported 
the greatest improvement regardless of the type of psycho-
logical intervention received.25 However, it is important to 
note that the physical activity intervention was delivered in 
conjunction with manualised psychological therapies by 
research therapists rather than as part of routine clinical 
care.
study rationale
Current first-line treatments for depression in young 
people are, at best, modestly effective. Augmentation 
with an additional intervention such as physical activity 
is a strong candidate to improve response to treatment. 
The results from our earlier study indicate that phys-
ical activity in combination with psychological treat-
ment is effective in reducing depression symptoms in 
young people.25 However, as clinicians do not routinely 
include physical activity interventions in standard care,28 
the opportunity to improve depression and functional 
outcomes and prevent poor physical health for young 
people with depression may be missed.13 28 This lack of 
integration likely occurs because clinicians are not aware 
of the evidence, are unsure how to implement physical 
activity interventions or lack the time and resources.28 29 
By providing training and clinical resources, the objective 
of the current study is to determine the effectiveness of 
a physical activity behaviour change intervention when 
used as an adjunct to routine clinical care, delivered in 
real-world mental health contexts.
MEthods And AnAlysIs
study aims
The aims of this study are to test the effectiveness of a phys-
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Figure 1 Flow chart of clinician and participant recruitment 
and study timeline.
with psychoeducation about physical activity, in addition 
to routine clinical care in improving depressive symp-
toms (primary outcome) in young help-seekers with 
depression. Secondary outcomes include the effect of the 
intervention on anxiety symptoms and functioning and 
to examine whether changes in physical activity mediate 
improvements in depressive symptoms.
study design
The study will use a parallel group, two-arm, cluster 
randomised controlled trial (C-RCT) design to test the 
effect of the physical activity intervention compared with 
psychoeducation, in addition to routine clinical care, 
with randomisation occurring at the clinician level (see 
figure 1). Randomising clinicians will reduce the contam-
ination associated with clinicians concurrently managing 
intervention and control participants, as would occur in 
a standard patient randomised trial.30 Assessment time 
points will be at baseline, intervention end-point (primary 
outcome) and 6 months (follow-up). The trial has 
well-defined objectives and protocols addressing Good 
Clinical Practice (GCP)31 and Standard Protocol Items: 
Recommendations for Interventional Trials guidelines.32 
Patients or the public were not involved in the design, or 
conduct, or reporting or dissemination of our research.
Setting headspace centres are accessible, communi-
ty-based mental health services that support young people 
aged 12–25 years, funded by the Australian federal govern-
ment.33 Services are delivered in a youth-friendly environ-
ment staffed by a range of service providers, including 
general practitioners, psychologists, psychiatrists, youth 
workers, mental health nurses and other allied health 
professionals. headspace centres assess approximately 850 
new patients per year, 40% presenting with depression.34 
A subset of approximately 6 of the more than 100 head-
space centres will be involved in this study.
Participant and recruitment procedures
Clinicians
All allied health professionals, including psychologists, 
social workers and occupational therapists (‘clinicians’), 
who provide mental health treatments to young people 
in the participating headspace centres will be invited to 
participate in the study and will be randomised to deliver 
either the intervention group (physical activity behaviour 
change) or the control group (psychoeducation), in addi-
tion to routine clinical care. Clinicians in predominantly 
intake and assessment roles will not be included.
Participants
All help-seeking young people aged 12–25 years who 
present to participating headspace centres will be screened 
for eligibility. We aim to recruit a total of 960 participants. 
Informed consent will be obtained from all participants; 
those aged between 15 years and 18 years will be assessed 
for mature minor capacity35 during the intake assessment 
procedure at entry to the service and, if they meet this 
threshold, will be able to make the decision whether or 
not to consent to participate. Those aged 12–14 years can 
provide assent to participate but will also require parental/
legal guardian consent. After obtaining informed consent, 
participants will be screened by research assistants who 
will: (A) assess the eligibility of the young person and (B) 
collect outcome data (interview and self-report) at base-
line, post-treatment and 6-month follow-up assessments.
Patient and public involvement
No patient involved.
Inclusion, exclusion and discontinuation criteria
Inclusion criteria
(1) Meeting the requirements for a Mental Health Treat-
ment Plan to access up to 10 sessions of psychological 
treatment under the Medicare Benefits Scheme Better 
Access programme per annum36; and (2) a Quick Inven-
tory of Depressive Symptomatology-Adolescent (17 item) 
- Clinician Rated (QIDS-A17-C)37 score of 11 or greater, 
indicating depression levels of moderate or above.
Exclusion criteria
(1) Presence of a psychotic disorder or eating disorder 
during the intake assessment on first presentation to the 
headspace centre38; (2) current physical activity meeting 
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under 18 years, 60 min of moderate to vigorous activity 
every day; for those over 18 years, 30 min of moderate 
activity at least five times for week)39 40; (3) physical illness 
that contraindicates participation in physical activity; (4) 
organic mental disorder; and (5) intellectual disability/
cognitive impairment that precludes providing informed 
consent, as assessed by the headspace intake and access 
team members and the study’s research assistants and 
referred for review to the study site’s principal investi-
gator or clinical review team. Any young person reporting 
a prior history of physical illness that might impede their 
ability to take part in physical activity will be required to 
receive medical clearance from a general practitioner in 
order to participate in the trial.
Discontinuation criteria
(1) Incidence of a psychotic disorder or eating disorder 
meeting diagnostic threshold or (2) physical illness 
that contraindicates participation in physical activity, as 
assessed by the treating clinicians during the course of the 
intervention. Discontinuation from the active or control 
interventions can be at the request of the participant or if 
any changes in the participant’s presentation warrants a 
referral to another service, as determined by their treating 
clinician or clinical review team. These participants will 
discontinue their assigned intervention but will remain 
involved in the postintervention assessment.
Interventions
The interventions will be integrated into routine clinical 
care and delivered by a headspace clinician, which may also 
include probationary psychologists (graduate trainees) 
on clinical placement. The current funding rules of 
the Medicare Benefits Schedule allow for six sessions of 
psychological treatment (plus an additional four if clini-
cally warranted) per calendar year. We anticipate that the 
interventions (both physical activity and control) will be 
delivered in an average of four treatment sessions across 
approximately 4–6 weeks, consistent with the average 
national attendance rates to headspace centres.41 The 
intervention will be capped at a maximum of 10 sessions. 
The active and control interventions have been described 
to meet the Template for Intervention Description and 
Replication standards.42 At the first treatment session, 
participants will be provided with relevant materials and 
resources according to the treatment condition to which 
their treating clinician has been assigned.
Physical activity intervention
Participants who receive treatment from a clinician who 
has been allocated to this group will receive a manual-
ised integrated physical activity behaviour change inter-
vention, as per the training delivered to the clinicians, 
within their psychological treatment sessions. Treat-
ment sessions will be delivered face to face and onsite 
at each participating headspace centre. The IMPACT 
treatment manual includes evidence-based behaviour 
change techniques, targeting self-regulation (planning 
and organising), motivation, enjoyment and tailoring 
for individual needs.43 44 Participants will be encouraged 
to set short-term and longer term specific and measure-
able goals; monitor progress towards these goals; discuss 
the benefits of physical activity; consider factors that may 
facilitate their participation (eg, enlisting support from 
others and choosing physical activities that are enjoy-
able)44 45; and identify potential barriers and strategies for 
overcoming these barriers. Clinicians will review weekly 
goals, participants’ self-monitoring of mood preactivity 
and postactivity, addressing barriers and enhancing indi-
vidual facilitators, reinforcing achievements and revising 
physical activity plans in each weekly session of psycho-
logical treatment to facilitate an increase in engagement 
in physical activity.46 The intervention is designed to be 
delivered within 15–20 min to the initial session, with 
5–10 min duration in subsequent sessions. Given the 
real-world nature of the intervention context, it is not 
possible to define the frequency of sessions or duration 
of the intervention period a priori, due to variation in 
each of the study sites in terms of allocation to clinicians, 
managing service demands and appointment scheduling.
Participants will receive verbal and written information 
about the relationship between depressive symptoms and 
exercise47; access to online resources providing advice and 
instructions on physical activities; minimal equipment 
(resistance band for resistance activity and skipping rope 
for cardiovascular physical activity); written worksheets 
and resources to enhance motivation, address barriers 
and provide physical activity suggestions, including the 
current Australian national physical activity and sedentary 
behaviour guidelines48 49; and a weekly planner to discuss 
and plan for how and when the physical activity can be 
completed and any memory aids that could be used to 
aid in completion of this (including mobile technology 
applications (‘apps’)).
Psychoeducation intervention
Participants who receive treatment from a clinician who 
has been allocated to this group will be provided with the 
same psychoeducation about the relationship between 
depressive symptoms and physical activity as the interven-
tion group, within the first treatment session only. Treat-
ment sessions will be delivered face to face and onsite at 
each participating headspace centre. The inclusion of the 
control group intervention is to examine whether the 
provision of information about physical activity for mental 
health and minimal resources is sufficient for partici-
pants to increase their current levels of physical activity. 
This will include providing the same verbal and written 
information about the relationship between depressive 
symptoms and exercise47; minimal equipment (resistance 
band for resistance activity and skipping rope for cardio-
vascular physical activity); and physical activity sugges-
tions, including the current Australian national physical 
activity and sedentary behaviour guidelines,48 49 that will 
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of physical activity for depression will be addressed in the 
first session but will not be included in ongoing treatment.
study hypotheses
Primary: that the physical activity intervention will lead 
to greater reductions in depressive symptoms compared 
psychoeducation on physical activity, in addition to 
routine clinical care,
Secondary: (A) that the physical activity intervention 
will lead to greater reductions in anxiety symptoms and 
greater improvements in functioning, when compared 
with the control condition; and (B) that changes in 
depressive symptoms will be mediated by increases in 
physical activity.
Primary outcome
The primary outcome will be level of depression symptoms 
postintervention and at 6-month follow-up, measured by 
the QIDS-A17-C.37
secondary outcomes
Physical activity (mediator): levels of physical activity 
measured by the International Physical Activity Question-
naire50 and an electronic accelerometer device worn for 
5–7 days.
Mental health and substance use: anxiety symptoms 
measured by the Overall Anxiety Severity and Impairment 
Scale51; depression module from the Structured Clinical 
Interview for DSM-IV52; and substance use measured by 
the WHO Alcohol, Smoking and Substance Involvement 
Screening Test.
Anthropomorphic and lifestyle variables: height, weight 
and hip and waist measurements to determine body 
mass index and hip/waist ratio; Pittsburgh Sleep Quality 
Index53; and the Simple Dietary Questionnaire.
Functioning: Social and Occupational Functional Assess-
ment Scale54; and Australian Quality of Life Scale for 
adolescents55 to facilitate future cost utility and other 
economic analyses.
Variables that will be the subject of subsequent exploratory 
analyses include: self-efficacy measured by General Self 
Efficacy Scale56 and Barriers Self-Efficacy Scale (physical 
activity)57; Perceived Social Support Scale; Positive and 
Negative Affect Schedule58 Cognitive and Behavioural 
Therapy Skills Questionnaire59; Behavioural Activation 
for Depression Scale60; Montgomery Asberg Depression 
Rating Scale61; and Working Alliance Inventory (thera-
peutic alliance)62; and the Trail Making Test A & B63 64 to 
assess attention, processing speed and mental flexibility.
Assessments and measures will be conducted as per the 
assessment schedule: (1) screening for eligibility; and 
(2) baseline, postintervention (end-point) and 6-month 
follow-up assessments. Data from participating young 
people will be entered into a project-specific secure 
online database at all assessment time-points, using a 
reversible process in which the identifiers are removed 
and replaced by a code.
Process and implementation measures
Training
All participating clinicians will be trained in GCP and 
IMPACT study procedures, delivered in a 1.5-hour session 
in face-to-face format. Additionally, all participating 
clinicians will participate in a further 30 min training 
session on how to deliver the psychoeducation on phys-
ical activity and share resources with participants in the 
study. Following this, all clinicians who are randomised 
to the physical activity intervention group will take part 
in an additional 60 min training session to integrate the 
IMPACT intervention into routine clinical care. For the 
intervention group, skills, knowledge and attitudes will be 
assessed before and after the training session, measured 
by the Theoretical Domains Framework questionnaire.65
The face-to-face training will be supported by additional 
online resources using a learning management system that 
will host an electronic version of the intervention manual, 
project resources, training videos and case vignettes. The 
training will incorporate practice recommendations for 
delivering physical activity behaviour change interven-
tions for mental health, including: (A) creating indi-
vidual training plans to increase adherence and aim to 
increase physical activity levels and decrease sedentary 
behaviours, (B) integrating the physical activity interven-
tion into routine psychoeducation and psychotherapy; 
and (C) incorporating evidence-based behaviour change 
techniques, targeting self-regulation (planning and organ-
ising), motivation, enjoyment and tailoring for individual 
needs.43 44 Clinicians will be provided with a comprehensive 
IMPACT treatment manual66 and the resources required to 
deliver the intervention (handouts, worksheets and access 
to online materials). Clinicians in the control condition will 
not have access to the online support materials.
Fidelity
Fidelity will be assessed using a brief checklist to be 
completed by clinicians after each session to estimate 
time spent on the intervention and the type of psycholog-
ical treatment that was delivered as part of routine care 
(eg, CBT and interpersonal therapy). Fidelity will also be 
assessed by audio recording of all treatment sessions, with 
a random subset of 10% of the recordings to be coded 
by an independent rater for adherence to the treatment 
manual and to discriminate between the intervention 
and control conditions. Fidelity will be maintained by 
offering quarterly online group peer supervision sessions 
for the clinicians in the intervention group to allow group 
discussion and case presentations, in addition to the 
face-to-face training at the commencement of the trial. 
Less frequent peer supervision (approximately every 6 
months) will be offered to the control group clinicians. 
Fidelity of the intervention will also be assessed using a 
checklist of components of the active and control condi-
tions collected from participants at the postintervention 
assessment. In addition, at the end of the intervention 
period, a subgroup of physical activity intervention group 
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in semistructured interviews to explore their experiences 
of delivering and receiving the intervention, respectively.
randomisation and allocation to treatment
Clinicians will be allocated to the intervention and control 
groups using a minimisation procedure commencing 
with random assignment.67 The procedure was devised by 
the study statistician (AM) and will be carried out by an 
independent researcher, following the ICH Guideline,68 
to ensure allocation concealment. Minimisation factors 
to be incorporated are gender of clinician (two-level 
factor: male/female), background training of clinician 
(two-level factor: psychologist/non-psychologist) and 
headspace centre, to ensure equal numbers in each inter-
vention at each site (six centres). Participants will be strat-
ified by age (≤17 and 18+ years), gender (male/female) 
and QIDS-A17-C score (≤15 and 16+). Participants will be 
assigned to a clinician based on a randomised list. Due to 
the nature of the intervention, it will not be possible to 
blind the clinicians and participants; however, all prein-
tervention, postintervention and follow-up assessments 
will be conducted by research assistants blinded to treat-
ment allocation. Investigators not involved in the delivery 
of the intervention and the trial statistician will be blind 
to group allocation until the analysis is completed.
statistical analysis
Analysis plan
Primary quantitative analyses will be undertaken on 
an intent-to-treat basis, including all participants as 
randomised, regardless of treatment received or with-
drawal from the study. Linear mixed models will be 
used to analyse change in the primary outcome measure 
(QIDS-A17-C). Models will include a random ‘clinician’ 
factor. Correlation of repeated outcome measures will 
be accommodated using an unstructured variance–
covariance matrix. An a priori planned comparison of 
change from baseline to the postintervention assessment 
will be used to test the primary hypothesis. Comparison 
of change from baseline to follow-up between arms will 
be undertaken as a secondary outcome analysis. Factors 
used in assignment by minimisation (clinician gender, 
discipline and headspace centre) will be introduced in 
models as covariates and retained if significant. Variables 
associated with participant missingness or found to be 
substantially inbalanced between groups will be included 
in models on an exploratory basis.69
Mathematical transformation or categorisation of raw 
scores will be undertaken to meet distributional assump-
tions and address any violation of assumptions required in 
mixed models. When transformations have been under-
taken to better meet distribution assumptions, models 
using the transformed data will be considered the main 
test of the primary hypotheses. Mixed models use all avail-
able data and do not involve any substitution of missing 
values with supposed or estimated values. The assump-
tions underlying mixed modelling allow ‘missingness’ to 
be related to observed variables in the analysis but not to 
unobserved values (termed ‘missing at random’).70
Similar analyses of scaled secondary measures will 
assess differential change due to intervention arm. For 
dichotomous outcomes such as diagnoses and ordinal or 
count outcomes, comparable generalised mixed model-
ling approach will be used. Relative and reduction in risk 
of depression based on SCID diagnostic status will be 
estimated at the trial end-point and follow-up. Numbers 
needed to treat will be derived from these values. All anal-
yses will use two-sided tests, with an alpha value set at 0.05. 
In the event of substantial missingness, sensitivity analyses 
based on identified clinically plausible mechanisms may 
be undertaken to determine the robustness of findings.
Qualitative analyses of the semistructured inter-
views included within the process and implementation 
measures will be undertaken on audio-recorded inter-
views that will be transcribed verbatim, with data analysed 
using thematic analysis.71
Power analysis
Calculations of required sample size were based on 
detecting a postintervention effect size of 0.34, which is at 
the lower boundary of utility and also reflects the adjunc-
tive status of the intervention. Power was set at 0.90, 
alpha=0.05 (two tailed) and correlation of 0.5 assumed 
between pretreatment and post-treatment scores. To 
allow for possible clustering effects (participants with the 
same therapist having characteristics and outcomes more 
alike than between therapists), a design effect72 was calcu-
lated assuming an intraclass correlation (ICC) of 0.05 and 
the number of clients per therapist up to 24. The estimate 
of the ICC is at the upper range of therapist effects and is 
conservative given the prescribed, manualised nature of 
the intervention. It is anticipated that 6–8 clinicians per 
headspace centre will be involved in the study. The resul-
tant design effect of 2.15 reflects the possible non-inde-
pendence of cluster-sampled participants and was used 
to inflate the calculated sample size, which assumes inde-
pendence. The estimated required sample size was 784. 
To accommodate a potential attrition/withdrawal rate of 
up to 20%, the target sample size was set at 960 or 480 
participants per condition.
safety procedures and oversight
Each participating headspace centre will have a principal 
site investigator and will also be required to nominate a 
lead clinician who will be responsible for the oversight of 
participant safety during the course of the trial. Withdrawal 
from the study can be at the request of the participant or if 
the participant meets discontinuation criteria. Once with-
drawn, the young person will be reviewed using the head-
space centre’s standard clinical review procedure and either 
maintained in the headspace centre or referred to other 
services as necessary. Any adverse incident, any serious or 
unanticipated adverse effects of the research on study partic-
ipants, and unforeseen events that might affect continued 
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reported until resolution, stabilisation or the participant is 
lost to follow-up, unless the condition is unlikely to resolve 
as per the opinion of the medical practitioner appointed by 
the study sponsor to monitor adverse incidents. In the event 
of an adverse incident or unexpected outcome, the allied 
health professional or research personnel will report to the 
study sponsor, Orygen. If necessary, a decision will be made 
as to whether to withdraw or suspend participation. The 
study sponsor will conduct annual centralised monitoring 
visits of the study sites.
Ethics and dissemination
Revisions to the study protocol have been enacted 
following approval received from the HREC (latest 
version: Protocol Version 9, 1 April 2019), and these revi-
sions have been reported in the trial registry by the study’s 
clinical trial managers (CM and VR). Trial findings will 
be published in peer-reviewed journals and presented at 
conferences. Key messages will also be disseminated by 
the youth mental health services organisation (headspace 
National Youth Mental Health Foundation).
dIsCussIon
Depressive disorders are highly prevalent and are the 
leading cause of disability in young people worldwide. 
If effective, the physical activity intervention tested in 
this C-RCT has the potential to improve the immediate 
outcomes for young people with depression by providing an 
additive treatment effect in conjunction with routine clin-
ical care. Additional benefits may include improvements 
in social and vocational functioning, thereby reducing the 
likelihood of longer term damage in these domains.
The IMPACT intervention is easily scalable. As it is set 
within the national network of headspace centres, this will 
increase the likelihood that any benefits are translated 
into routine clinical practice for the many thousands of 
young people who access headspace services per annum. 
There is also potential to adapt the intervention for other 
service delivery models (eg, primary care and tertiary 
mental health services) nationally and internationally—
including in regional and remote areas—which may be 
of interest to policy makers and those funding mental 
health programmes or services.
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